Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IFx-Hu2.0 |
Synonyms | |
Therapy Description |
IFx-Hu2.0 comprises a DNA vector encoding the strepococcal membrane protein Emm55, which may result in increased anti-tumor immune response and decreased tumor growth (Cancer Res July 1 2019 (79) (13 Supplement) CT119). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IFx-Hu2.0 | IFx-Hu2.0 comprises a DNA vector encoding the strepococcal membrane protein Emm55, which may result in increased anti-tumor immune response and decreased tumor growth (Cancer Res July 1 2019 (79) (13 Supplement) CT119). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04925713 | Phase I | IFx-Hu2.0 | IFx-Hu2.0 for the Treatment of Patients With Skin Cancer | Completed | USA | 0 |
NCT04160065 | Phase I | IFx-Hu2.0 | Immunotherapy With IFx-Hu2.0 Vaccine for Advanced MCC or cSCC | Active, not recruiting | USA | 0 |
NCT03655756 | Phase I | IFx-Hu2.0 | pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma | Completed | USA | 0 |